Federal drug agents search six Walgreens stores in Florida as part of investigation into prescription pain medicine abuse; agents probing whether chain allowed overly large numbers of pain pill sales

Cindy Allen

Cindy Allen

Apr 9, 2012 – Associated Press

April 9, 2012 () – A new media report says that federal drug agents searched six Walgreen stores in Florida and a distribution center there as part of investigation into prescription pain pill abuse.

The Wall Street Journal reported that the Drug Enforcement Administration is looking at whether Walgreen allowed a suspiciously large number of pain pill sales, which agents believe could indicate that they are being diverted to drug dealers and addicts.

Michael Polzin, a spokesman for the country's largest drugstore operator, said the Deerfield, Ill., company is cooperating with the DEA.

The Journal reported in an update to its website Thursday that the stores are located in southern and central Florida, and the distribution center is in Jupiter, Fla.

Earlier this year, the DEA moved to suspend the sale of controlled substances by two CVS pharmacies in the Orlando area, and the shipment of them from Cardinal Health Inc.'s Lakeland, Fla.-based center that supplied the stores.

The DEA says the pharmacies were dispensing the painkiller oxycodone far in excess of legitimate needs. CVS-Caremark Corp., the second-largest pharmacy chain after Walgreen, has said it has taken steps to reduce the prescriptions.

© 2021 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025 795

+1 (310) 558 0008
+1 (310) 558 0080 (FAX)

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.